Literature DB >> 31157926

Exploring biomarkers in the overactive bladder: Alterations in miRNA levels of a panel of genes in patients with OAB.

Elif Fırat1, Zafer Aybek2, Şakir Akgün3, Kürşat Küçüker2, Hakan Akça4, Hülya Aybek1.   

Abstract

AIMS: It has been demonstrated that there are abundant stable microRNAs (miRNAs) in plasma, which is potentially disease-specific. Adrenergic and muscarinic pathways play an important role in voiding physiology. Alterations in the levels of miRNAs are thought to influence the regulation of these pathways at the molecular level. The aim of this study was to investigate the relationship of miRNAs with overactive bladder pathogenesis and to provide a new perspective to treatment approaches.
METHODS: This study included patients with an overactive bladder (OAB) diagnosis and a healthy control group. All patients completed a validated OAB-V8 questionnaire. The relative expression levels of 12 miRNAs were examined in plasma by PCR. Receiver operating characteristic (ROC) curves were generated to evaluate the diagnostic qualification of miRNAs.
RESULTS: The relative expression levels of let-7b-5p, miR-92a-3p, miR-98-5p, miR-142-3p, and miR-200c-3p were significantly upregulated and miR-139-5p was significantly downregulated in patients with OAB and no correlation was determined between the levels of miRNAs with OAB symptom score. Among the miRNAs, miR-98-5p provided the highest diagnostic accuracy alone (area under curve [AUC] = 0.79) in ROC analysis. The combination of miR-98-5p + miR-139-5p was seen to be a good indicator (AUC = 0.839).
CONCLUSIONS: These results suggest that alteration of the miRNA levels can be used as auxiliary parameters to explain the pathophysiology of OAB syndrome and could shed light on new treatment options.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  biomarkers; microRNA; overactive bladder

Mesh:

Substances:

Year:  2019        PMID: 31157926     DOI: 10.1002/nau.24065

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  4 in total

1.  MicroRNA expression profile in the spinal cord injured rat neurogenic bladder by next-generation sequencing.

Authors:  Zhenhua Shang; Tongwen Ou; Jianjun Xu; Hao Yan; Bo Cui; Qi Wang; Jiangtao Wu; Chunsong Jia; Xin Cui; Jin Li
Journal:  Transl Androl Urol       Date:  2020-08

2.  Potential Role of Monocyte Chemoattractant Protein-1 in Monitoring Disease Progression and Response to Treatment in Overactive Bladder Patients.

Authors:  Gamal Ghoniem; Bilal Farhan; David Csuka; Frank Zaldivar
Journal:  Int Neurourol J       Date:  2020-12-31       Impact factor: 2.835

3.  ADRB3, ROCK2, and GEF Levels in Overactive Bladder Patients.

Authors:  Elif Fırat; Zafer Aybek; Hülya Aybek
Journal:  Int Neurourol J       Date:  2022-02-28       Impact factor: 2.835

4.  Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells.

Authors:  Przemysław A Stempor; Dror Avni; Raya Leibowitz; Yechezkel Sidi; Maria Stępień; Tomasz Dzieciątkowski; Paula Dobosz
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.